Precision Medicine in Oncology

Patient Understanding of Precision Oncology, QOL Implications Continues to Increase

July 30th 2021, 1:30pm

Article

Understanding of precision oncology has grown among patients, according to the researchers, who explained that in 2012, less than 50% of surveyed patients knew what “precision oncology” meant.

Dynamic MRD Can Drive Clinical Decisions in AML

July 23rd 2021, 1:00pm

Article

Dynamic measurable residual disease (MRD) can be used to optimize postremission treatment for young patients with acute myeloid leukemia (AML).

Number of Plasma Variants Associated With Lung Cancer Survival, Says Liquid Biopsy Analysis

July 18th 2021, 1:00pm

Article

Researchers have found that the number of variants a patient had in their plasma had prognosis implications, with circulating cell-free DNA mutational load having a significant association with overall survival.

Dr Christopher Arendt on Indication of TKIs in Solid Tumor and Blood Cancers

July 17th 2021, 4:30pm

Video

Christopher Arendt, PhD, head, Oncology Therapeutic Area Unit, Takeda, speaks on the success of tyrosine kinase inhibitors (TKIs) in the treatment of blood cancers and efficacy implications of these therapies for solid tumor cancers.

Genomics-Informed Treatment Prolongs Time to Treatment Discontinuation, Study Says

July 13th 2021, 11:30am

Article

Based on difference-in-difference (DID) analysis, genomics-informed treatment increased time to treatment discontinuation by an estimated 3 months and increased costs by an estimated C$90,000—equivalent to approximately US$72,000—compared with standard care treatment.

Oncology Value Coalition: Bringing Precision Medicine Solutions to the Cancer Journey, Part 7

July 12th 2021, 1:30pm

Webinar

In part 7 of the Oncology Value Coalition webinar, experts from City of Hope and Highmark discussed telehealth and the role of remote care.

Oncology Value Coalition: Bringing Precision Medicine Solutions to the Cancer Journey, Part 6

July 12th 2021, 1:15pm

Webinar

In part 6 of the Oncology Value Coalition webinar, experts from City of Hope and Highmark discussed examples of game-changing therapy in cancer care.

Oncology Value Coalition: Bringing Precision Medicine Solutions to the Cancer Journey, Part 5

July 12th 2021, 1:00pm

Webinar

In part 5 of the Oncology Value Coalition webinar, experts from City of Hope and Highmark discussed why AccessHope offers an option to payers and oncologists.

Oncology Value Coalition: Bringing Precision Medicine Solutions to the Cancer Journey, Part 4

July 12th 2021, 12:45pm

Webinar

In part 4 of the Oncology Value Coalition webinar, experts from City of Hope and Highmark discussed how the therapeutic pipeline has changed.

Oncology Value Coalition: Bringing Precision Medicine Solutions to the Cancer Journey, Part 3

July 12th 2021, 12:30pm

Webinar

In part 3 of the Oncology Value Coalition webinar, experts from City of Hope and Highmark discussed the payer perspective in the rise of genomics.